Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...

On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...

AstraZeneca (AZN) announced on Wednesday that its late-stage trial of Fasenra in patients with chronic obstructive pulmonary ...

AstraZeneca ( NASDAQ: AZN) said that the late-stage trial for its medication Fasenra (benralizumab) in patients suffering ...

AstraZeneca's Fasenra misses the primary COPD endpoint while Saphnelo's lupus trial shows significant improvements and ...

AstraZeneca said on Wednesday its asthma drug Fasenra failed to control the rate of flare-ups in patients with chronic ...

Among patients with COPD, at least 50% reported that the disease impacts their daily life and emotional health, according to ...

A recent study reveals that COPD, or Smokers' Disease, is impacting younger individuals. Doctors in Delhi are observing a ...

While there has been progress against chronic disease, the U.S. has been backsliding against big killers like heart disease.

Content by Health System. With Asthma Peak Week typically during the middle of September, now is a great time to learn the ...

New research from the University of Copenhagen shows that team sports are a highly effective and potentially life-extending form of exercise for patients with high blood pressure and COPD. Even after ...

“Without appropriate preparation and intervention, patients may experience significant hypoxemia in flight, which can lead to ...